northeast region conference exhibition  
  Sponsors: New Hampshire, Vermont & Massachusetts Chapters and Sections of CLMA, AACC and CLAS
 
 

SPEAKERS

Speakers and Guest Lecturers at Northeast Region Conference and Exhibition

keynote speakers, seminar leaders, moderators, celebrity headliners, sports stars, adventurers, media personalities, political leaders, business speakers, industry experts, gurus, authors, military leaders, technology speakers, sales trainers, coaches, consultants, futurists, and motivational speakers

Day 1: Tuesday, April 16th

Program Management

JoAnne Milbourn, MS, MT(ASCP), has more than 30 years experience in healthcare within hospitals and integrated health systems, information technology organizations, commercial reference laboratories, and ambulatory and physician provider settings. She is currently working in the role of a Customer Program Executive for McKesson's Program Management Office, having previously worked with McKesson's Clinical Consulting Services group as an Engagement Manager and Ancillary Solutions Practice Leader. Ms. Milbourn has held previous positions as an internal laboratory consultant for a physician practice management company, manager of a hospital based laboratory provider organization and administrative director positions within hospital and commercial reference laboratories. Read a summary of Ms. Milbourn's Presentation.

Jeffrey F. Boothe, is a Partner in the law firm Holland & Knight LLP, Washington, DC 20006

Paul D. Camara, MS, is the Vice President , Clinical consulting, Applied Management Systems, Inc in Burlington Ma. He brings over 25 years of progressive healthcare management experience to AMS. His expertise includes direction of clinical laboratories as well as diagnostic imaging, cardiology, and radiation oncology departments.

Changes in Testing

Paul D'Orazio, PhD, is R&D Director - Critical Care Analytical at Instrumentation Laboratory, Lexington, Massachusetts. He received a PhD in Analytical Chemistry from the State University of New York at Buffalo in 1979 and has been employed in the diagnostics industry for almost 30 years, formerly with Bayer Diagnostics and at Instrumentation Laboratory since 1999. His interests include development and integration of chemical sensors and biosensors into instrumentation for critical care and point of care testing. Paul is past chair of the AACC Critical and Point of Care Testing Division and Industry Division. He has been active in NCCLS/CLSI as a member of the Area Committee on Clinical Chemistry and Toxicology and former chair of the Subcommittee on Electrolytes. He also serves as a member of the IFCC Working Group on Selective Electrodes and Point of Care Testing and editorial board member for Point of Care: The Journal of Near Patient Testing and Technology. Paul holds several patents in field of chemical sensing and application of this technology to medical diagnostics.

James H. Nichols, Ph.D., DABCC, FACB, is an Associate Professor of Pathology at Tufts University School of Medicine and Director, Clinical Chemistry for Baystate Health in Springfield, MA. Jim received his B.A. in General Biology/Premedicine from Revelle College, University of California at San Diego. He went on to complete a Masters and Doctorate in Biochemistry from the University of Illinois, Urbana-Champaign. Dr. Nichols was a fellow in the Postdoctoral Training Program in Clinical Chemistry at the Mayo Clinic, Rochester, MN. He is board certified in both Clinical Chemistry and Toxicological Chemistry by the American Board of Clinical Chemistry. Dr. Nichols spent several years as Associate Director of Clinical Chemistry, Director of Point-of-Care Testing, and an Associate Professor of Pathology at Johns Hopkins Medical Institutions prior to moving to Massachusetts. Baystate Health includes Franklin Medical Center, Mary Lane Hospital and Baystate Medical Center, a leading acute care center in New England. Jim is responsible for Clinical Chemistry including core automated chemistry, immunoassay, endocrinology, toxicology/therapeutic drug analysis, estoteric and point of care testing conducted through Baystate Reference Laboratories, one of America's largest hospital-based outreach programs. Dr. Nichols' research interests span evidence-based medicine, information management, laboratory automation, point-of-care testing and toxicology.

Barbara Goldsmith, is the Vice President of Laboratory Services for Caritas Christi Health Care, a six hospital system in Boston, Massachusetts. Dr. Goldsmith is also president elect of AACC. Read More About Dr. Goldsmith's Presentation

Lynn A. Cheryk, Ph.D., DABCC, FACB - serves as Laboratory Director of Mayo Medical Laboratories New England (Wilmington, MA). Dr. Cheryk began her career in laboratory medicine as a fellow at the Mayo Clinic (Rochester, MN). Following several years in the IVD industry, Dr. Cheryk returned to clinical laboratory medicine as the Laboratory Director of Mayo Medical Laboratories New England. She also serves as Adjunct Professor in the Department of Clinical Laboratory and Nutritional Sciences at the University of Massachusetts Lowell, as well as an Associate Professor in the Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine in Rochester, MN.

Laboratory Outreach

Robert Page, is the Director of Laboratory and Surgical Pathology, Newton-Wellesley Hospital Newton, MA

Pamela F. May RM (AAM) MPH, is Corporate Team Lead - Clinical Systems, Partners HealthCare System, Inc

Frank A. Fornari, Ph.D., is the chief Executive Officer at Dominion Diagnostics, LLC, North Kingstown, RI


Emerging Technologies

Gyorgy Abel, MD, PhD, DABCC, FACB is the Director of the Clinical Immunology and Molecular Diagnostic Laboratories at Lahey Clinic, Burlington, MA, and Clinical Instructor in Pathology, Harvard Medical School. Dr. Abel graduated from the Medical School of Debrecen, Hungary in 1978, followed by a residency and board certification in Clinical Laboratory Diagnostics. Gyorgy moved to the United States in 1988 and worked as a Research Fellow at the Department of Rheumatology and Immunology at the Brigham and Women's Hospital, Harvard Medical School, where he gained expertise in molecular biology. In 1992 he joined the Department of Laboratory Medicine, Lahey Clinic, Burlington, MA, as a staff scientist and made significant contributions to research projects on the immunopathology of hepatitis C infection. Dr. Abel then entered a second residency in Clinical Pathology in the Massachusetts General Hospital in 1998. He completed the program as chief resident in 2000 and became board certified in Clinical Pathology (ABP) and in Molecular Diagnostics (ABCC). He returned to Lahey Clinic in the same year and became the Director of the Clinical Immunology and Molecular Diagnostics Laboratories. He teaches medical students and pathology residents at Harvard Medical School. Gyorgy is the Chair-Elect of the Clinical and Diagnostic Immunology Division of AACC, he organized several division events, including the annual Issues in Immunodiagnostics Symposia. He also serves as a Director of the American Board of Clinical Chemistry.

Martin Fleisher, PhD, is the Chairman of the Department of Clinical Laboratories and Chief of the Clinical Chemistry Service at the Memorial Sloan-Kettering Cancer Center in New York City. Dr. Fleisher has over thirty years experience in discovery and application of new tumor markers and biomarkers for the early detection of cancer. His interest in biomarkers was initiated by the validation of Carcinoembryonic Antigen (CEA) in colon cancer. His seminal work on the relationship between breast cancer and cystic mastopathy involved over 80 analytes, and included biomarkers consisting of peptides, proteins, enzymes, hormones, immunoglobulins and trace metals. He has investigated the use of biomarkers, such as urokinase plasminogen activator (uPA) and plasminogen activator inhibitor 1(PAI-1) as prognostic markers in women with node negative breast cancer.

Dr. Fleisher has spent his career in the discovery, development and clinical association of biomarkers that help in the early detection of cancer. He developed chromatographic methods for the determination of urinary metabolites used in the early detection and monitoring of neuroblastomas in children. In collaboration with his neuro-oncology colleagues he developed a panel of tumor markers in cerebrospinal fluid that help identify the presence of central nervous system tumors (leptomeningeal metastasis). He has developed and validated assays for the management of patients with B-cell dyscrasias with amyloidosis(free serum lambda and kappa light chains), biomarkers helpful in the prognostic evaluation of patients with ovarian cancer(YKL-40 and MMP-9), the use of circulating tumor cells(CTC) in patients with metastatic prostate cancer, and the development of a bone marker panel(osteocalcin, bone specific alkaline phosphatase, N-telopeptide, and Vitamin D) to detect the affects of tyrosine kinase inhibitors(imatinib)in patients with CML and GIST(NEJM May 2006). Dr. Fleisher's research focus is on the development of new, rapid, and inexpensive bioassays for detecting and monitoring cancer. Dr. Fleisher is President of the Clinical Ligand Assay Society. View a summary of Dr. Fleisher's presentation.

Salvatore L. Perla MS, MT(ASCP), CLS(NCA). Is the Vice President, clinical and Support Services at Milford Regional Medical Center in Milford MA. He is the Senior Manager for 10 clinical and support areas including, laboratory, blood bank, EEG/EMG, Respiratory, Rehab Services, Cancer Center, Food & Nutrition, Facilities, Security and Housekeeping.

Richard Kaufman, MD, is an Assistant Professor of Pathology , Harvard Medical School and the Blood Bank director at Brigham and Women's Hospital.

Workshop

Michele Hollingsworth MS, MT(ASCP), CLS(NCA). Is the Clinical Support and Training Manager at Iris Diagnostics in Chatsworth, California

Eric Burks, MD, is a staff Pathologist and Hematopathologist, Lahey Clinic, Department of Pathology, Lahey Clinic Medical Center, Burlington, MA

Debbie Low, MT(ASCP)SH, is an Account Manager for Sysmex America.

Norman Moore, Ph.D., received his doctorate in 1994 from the University of New Hampshire in Microbiology. He has been developing diagnostics throughout that time including FDA-approved tests for Influenza, RSV, Legionella, and S. pneumoniae. He is now the Director of Clinical Affairs at Inverness Medical Innovations.


Evening Dinner Presentation

Michael T. Bourke, PhD is a criminalist at the Connecticut State Police Crime Laboratory. He earned his doctoral degree at the University of Connecticut and did postdoctoral work at the University of Massachusetts Medical Center. He is currently responsible for analysis of evidentiary material, including the collection of trace and serological evidence samples. His primary duties use forensic DNA analysis of collected materials and the validation of additional DNA tests.

Day 2: Wednesday, April 16th Program


Management

Donna MacMillan, BSMT (ASCP), MBA is the Director of Operations for the Department of Pathology at the Massachusetts General Hospital. She is responsible for the technical performance of a full service, multi-specialty operation that includes the core laboratory (chemistry/hematology), microbiology, immunology, blood transfusion service, blood bank, blood donor program, cytology, surgical pathology, the autopsy service, two neighborhood health center laboratories and the hospital point of care program. She is serving on the Technical Expert Panel for the Medicare competitive bidding demonstration project. Donna has written and presented on topics including reimbursement, regulations, point of care testing, budgets and staffing issues for the laboratory service.

Desiree Carlson, MD, is board certified in Anatomic and Clinical Pathology, Blood Banking and Cytopathology. She is the Chief of Pathology and President of the Brockton Hospital Medical Staff in Brockton, Massachusetts. Dr. Carlson taught pathology at Harvard Medical School from 1977-1982 and at the Boston University School of Medicine from 1983-2003. She is a member of the College of American Pathologist's Commission on Laboratory Accreditation (CLA), and has served as the Northeast Regional Commissioner since 1991. She recently began serving the CLA as editor of Laboratory Accreditation News in 2001, a column published several times a year in CAP TODAY to inform participants and inspectors of program changes and developments. Dr. Carlson has been a volunteer inspector since 1978, and has performed over 35 laboratory inspections since 1993, most of them as team leader.

Mary Ellen Cortizas, PBT(ASCP), JD is Administrative Director of Laboratory Medicine at Children's Hospital Boston, and teaches the Laboratory Management course in Northeastern's Clinical Laboratory Science program

Ellen Neiduski, is an Independent Consultant

Changes in Testing

James L. Januzzi, Jr, MD, FACC, is an Associate Professor of Medicine, Harvard Medical school and the Director of the Cardiac Intensive Care Unit and Massachusetts General Hospital.

Petr Jarolim, MD, PhD, Director, Clinical Chemistry, Brigham and Women's Hospital and Dana Farber Cancer Institute, Associate Professor of Pathology, Harvard Medical School.

Lesley Stevens, MD, MS, Assistant Professor of Medicine, Tufts New England Medical Center

Timothy P. Skelton MD PhD, Dr. Skelton obtained a BS from MIT and MD PhD from Washington University in St. Louis. He completed a residency and research fellowship in clinical pathology at Massachusetts General Hospital (MGH) and Harvard University School of Medicine. He has held positions as Hematology Laboratory Director at MGH for 5 years, Assistant Director of Laboratory Medicine at Boston Medical Center for 3 years, and Core Laboratory Director at Lahey Clinic for the past 4 years. He has done research on the role of glycosylation on metastasis and the implications for tumor markers for 6 years.

Laboratory Outreach

M. William Lensch, Ph.D., is an Instructor in Pediatrics, Department of Pediatrics, Harvard Medical School and Affiliated Faculty, Harvard Stem Cell Institues. He is also an Associate Scientific Staff and Senior Scientist, Laboratory of George Q. Daley, M.D., Ph.D., Department of Medicine, Division of Hematology/Oncology , Children's Hospital Boston.

Marian J. Cavagnaro, MS, MT (ASCP) DLM, is Director of Laboratory Services, Memorial Hospital West

Mark A. Neuman, Ph.D., ABMM, FAAM, is the Director, Infectious Diseases, Molecular Diagnostics & Immunology Division, DSI Laboratories/LabCorp. Hospital Epidemiologist, NCH Healthcare system and Clinical Associate Professor os Internal Medicine, division of Infectious & Tropical Diseases, USF College of Medicine.

Del Gilbert, Over twenty five years of management experience in the healthcare environment with proven performance and increasing responsibility. Effective leader and trainer with exceptional communication and organizational skills. He is currently the Chief Learning Officer at St. Joseph Healthcare in Nashua, NH.

Emerging Technologies

Heidi L. Rehm, PhD, FACMG, Is an Associate Molecular Geneticist, Department of Pathology, Brigham & Women's Hospital and Center for Genetics and Genomics, Harvard Medical School and Partners Healthcare system.
Ahmed Tawakol, MD, is Co-Director, CIMIT Cardiovascular Program, Co-Director, Cardiac MR-PET-CT Program, Associate Director, Nuclear Cardiology, Massachusetts General Hospital. Dr Tawakol' group conducts translational and clinical studies using multi-modality imaging techniques, utilizing positron emission tomography (PET) in combination with CT and MR. Dr. Tawakol's primary research focus is functional imaging of atherosclerotic plaques.He is a graduate of Stanford Medical School. He completed Medical Residency and Cardiovascular Diseases Fellowship at Brigham and Women's Hospital, and completed a Nuclear Cardiology Fellowship at the Massachusetts General Hospital.
Marian J. Cavagnaro, MS, MT (ASCP) DLM, is Director of Laboratory Services, Memorial Hospital West

Terry Shirey, PhD, DABCC, Terry received a Ph.D. degree in biochemistry from Colorado State University and has had subsequent postdoctoral training in molecular biology at Johns Hopkins University and in laboratory medicine at SUNY Buffalo. He has directed hospital and reference laboratories. As a Clinical Biochemist at Nova Biomedical, he has developed a clinical studies program looking at critical care testing in many clinical settings. He has published and lectured on the findings from these studies internationally to many professional societies including those specializing in intensive care medicine, clinical anesthesia, pediatric laboratory medicine, critical care, and clinical pathology.

Workshops

Nancy E. Erickson PBT(ASCP), is a Certified Healthcare Instructor (NHA). Owner/Educator of Phlebotomy Education Inc. and Director of the Certification Preparedness Agency, Allen Park Michigan
Speakers | Biographies | Check in | Past Speakers | Summaries | Other Info

Print this Page | Bookmark: IE Users


©2007 Northeast Region Conference and Exhibition, All Rights Reserved. Privacy Policy | Legal

 

CLMA info AACC info CLAS info home page